Atlas Trials

An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms

Clinical trial NCT00161044 · COMPLETED

Trial details

NCT number
NCT00161044
Sponsor
University of Maryland, Baltimore
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Schizophrenia
Start date
2004-09-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.